Cross-presentation through langerin and DC-SIGN targeting requires different formulations of glycan-modified antigens

C.M. Fehres; H. Kalay; S.C.M. Bruijns; S.A.M. Musaafir; M. Ambrosini; L. van Bloois; S.J. van Vliet; G. Storm; J.J. Garcia Vallejo; Y. van Kooyk

doi:https://doi.org/10.1016/j.jconrel.2015.01.040

Cross-presentation through langerin and DC-SIGN targeting requires different formulations of glycan-modified antigens

C.M. Fehres, H. Kalay, S.C.M. Bruijns, S.A.M. Musaafir, M. Ambrosini, L. van Bloois, S.J. van Vliet, G. Storm, J.J. Garcia Vallejo, Y. van Kooyk

Molecular cell biology and Immunology (VUmc)

Research output: Contribution to journal › Article › Academic › peer-review

62 Citations (Scopus)

Original language	Undefined/Unknown
Pages (from-to)	67-76
Journal	Journal of controlled release
Volume	203
DOIs	https://doi.org/10.1016/j.jconrel.2015.01.040
Publication status	Published - 2015

Access to Document

https://doi.org/10.1016/j.jconrel.2015.01.040

Cite this

Fehres, C. M., Kalay, H., Bruijns, S. C. M., Musaafir, S. A. M., Ambrosini, M., van Bloois, L., van Vliet, S. J., Storm, G., Garcia Vallejo, J. J., & van Kooyk, Y. (2015). Cross-presentation through langerin and DC-SIGN targeting requires different formulations of glycan-modified antigens. Journal of controlled release, 203, 67-76. https://doi.org/10.1016/j.jconrel.2015.01.040

@article{b58be1b954694bbfbe4da683e9cf3edd,

title = "Cross-presentation through langerin and DC-SIGN targeting requires different formulations of glycan-modified antigens",

author = "C.M. Fehres and H. Kalay and S.C.M. Bruijns and S.A.M. Musaafir and M. Ambrosini and {van Bloois}, L. and {van Vliet}, S.J. and G. Storm and {Garcia Vallejo}, J.J. and {van Kooyk}, Y.",

year = "2015",

doi = "https://doi.org/10.1016/j.jconrel.2015.01.040",

language = "Undefined/Unknown",

volume = "203",

pages = "67--76",

journal = "Journal of controlled release",

issn = "0168-3659",

publisher = "Elsevier",

}

TY - JOUR

T1 - Cross-presentation through langerin and DC-SIGN targeting requires different formulations of glycan-modified antigens

AU - Fehres, C.M.

AU - Kalay, H.

AU - Bruijns, S.C.M.

AU - Musaafir, S.A.M.

AU - Ambrosini, M.

AU - van Bloois, L.

AU - van Vliet, S.J.

AU - Storm, G.

AU - Garcia Vallejo, J.J.

AU - van Kooyk, Y.

PY - 2015

Y1 - 2015

U2 - https://doi.org/10.1016/j.jconrel.2015.01.040

DO - https://doi.org/10.1016/j.jconrel.2015.01.040

M3 - Article

C2 - 25656175

SN - 0168-3659

VL - 203

SP - 67

EP - 76

JO - Journal of controlled release

JF - Journal of controlled release

ER -